Schering-Plough to buy Akzo Nobel unit for $14.5B (USA Today)
Schering-Plough said Monday it will buy the pharmaceuticals division of Netherlands-based Akzo Nobel for $14.5 billion in cash, giving the U.S. drugmaker a range of women's health products and a pipeline of late-stage experimental medicines.

Schering-Plough to Buy Akzo's Drug-Making Division (Update13) (Bloomberg.com)
March 12 (Bloomberg) -- Schering-Plough Corp. agreed to pay $14.4 billion to acquire Akzo Nobel NV's Organon division, gaining the world's third-largest maker of birth-control pills and a stable of potential new drugs.